entertainment -WSS

entertainment

author：knowledge 2025-10-02 11:10:31 - browse：12799

Anthony Fernandez holds a Wegovy injection, the ALP-1 agonist medication he uses to help curb his food cravings – Obesity medication and science coverage for STAT — A person holds a Wegovy injection pen. Kayana Szymczak for STAT

Medicare confirmed this week that it will cover Novo Nordisk’s obesity drug Wegovy if prescribed to prevent heart problems, but policy experts said Medicare patients are still likely to encounter significant barriers getting access to the highly popular and expensive drug.

Medicare previously wasn’t reimbursing for Wegovy, since the federal payer is legally barred from covering weight loss drugs. But the Food and Drug Administration this month approved Wegovy for preventing heart problems in people with obesity and heart disease, leading many to suspect that Medicare would start covering the drug for this usage.

Makers of obesity drugs have been hoping that showing additional benefits beyond weight loss would induce more insurers to cover them. Medicare’s guidance, first reported Thursday, moves in that direction, but experts point out that the private insurers that administer Medicare’s prescription drug benefit — called Part D — can still choose to not include Wegovy on their formularies, especially if they think it would be too costly.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Tori Bowie and the unacceptable rates of Black maternal death
Next article： STAT Summit: Doctor v. ChatGPT showed AI's promise, blind spots

hotspot

WSS

What to do when lifesaving products contribute to climate change

Diagnostic tests are hitting their mathematical limits

STAT Summit: Doctor v. ChatGPT showed AI's promise, blind spots

Readout Newsletter: AstraZeneca's CEO, Roivant's $5 billion deal

Pediatric cancer treatments threatened by a new FDA policy

Rep. Raul Ruiz on the physician shortage and more

focus

entertainment

explore

How to save PrEP access — and even expand it

Harvard's Jason Buenrostro wins MacArthur grant for genetics work

United colonoscopy coverage change 'may cost lives,' doctors say

UnitedHealth, Optum discontinue NaviHealth name

State Dept. review finds Biden bears some blame for Afghanistan failures

Fetal surgery at risk from Dobbs and new abortion restrictions

How one medical school became remarkably diverse

ADCs take center stage as promising cancer treatments

Continuity nursing helped my family in our darkest PICU moments

STAT Readout Newsletter: Biotech news today

explore

UnitedHealth has 90,000 doctors — 10% of all physicians in U.S.

Readout Newsletter: The latest in Pfizer, Moderna, and Sanofi

Why a market frenzy over new weight loss drugs defies logic

J&J to emphasize cancer drugs, stop much of its vaccine research

Harvard's Jason Buenrostro wins MacArthur grant for genetics work

Roche drug slashes death risk in early

hotspot

entertainment

hotspot

entertainment